Adil Javed to Disease Progression
This is a "connection" page, showing publications Adil Javed has written about Disease Progression.
Connection Strength
0.126
-
A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab. Mult Scler. 2019 05; 25(6):811-818.
Score: 0.112
-
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician. Lancet Neurol. 2008 Feb; 7(2):173-83.
Score: 0.014